Oric Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 10.61
| ORIC Stock | USD 10.61 0.39 3.55% |
Closest to current price Oric long PUT Option Payoff at Expiration
Oric Pharmaceuticals Target Price Odds to finish over 10.61
The tendency of Oric Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.61 | 90 days | 10.61 | about 51.47 |
Based on a normal probability distribution, the odds of Oric Pharmaceuticals to move above the current price in 90 days from now is about 51.47 (This Oric Pharmaceuticals probability density function shows the probability of Oric Stock to fall within a particular range of prices over 90 days) .
Oric Pharmaceuticals Price Density |
| Price |
Predictive Modules for Oric Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oric Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oric Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oric Pharmaceuticals is not an exception. The market had few large corrections towards the Oric Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oric Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oric Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | 1.07 | |
σ | Overall volatility | 1.63 | |
Ir | Information ratio | -0.08 |
Oric Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oric Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oric Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oric Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oric Pharmaceuticals has high historical volatility and very poor performance | |
| Oric Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (127.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Oric Pharmaceuticals currently holds about 227.06 M in cash with (112.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Oric Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Price-Driven Insight from for Rule-Based Strategy - Stock Traders Daily |
Oric Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oric Stock often depends not only on the future outlook of the current and potential Oric Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oric Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 69.7 M | |
| Cash And Short Term Investments | 256 M |
Oric Pharmaceuticals Technical Analysis
Oric Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Oric Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oric Pharmaceuticals. In general, you should focus on analyzing Oric Stock price patterns and their correlations with different microeconomic environments and drivers.
Oric Pharmaceuticals Predictive Forecast Models
Oric Pharmaceuticals' time-series forecasting models is one of many Oric Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oric Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Oric Pharmaceuticals
Checking the ongoing alerts about Oric Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oric Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oric Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oric Pharmaceuticals has high historical volatility and very poor performance | |
| Oric Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (127.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Oric Pharmaceuticals currently holds about 227.06 M in cash with (112.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Oric Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Price-Driven Insight from for Rule-Based Strategy - Stock Traders Daily |
Check out Oric Pharmaceuticals Analysis, Oric Pharmaceuticals Valuation, Oric Pharmaceuticals Correlation, Oric Pharmaceuticals Hype Analysis, Oric Pharmaceuticals Volatility, Oric Pharmaceuticals Price History as well as Oric Pharmaceuticals Performance. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Biotechnology sector continue expanding? Could Oric diversify its offerings? Factors like these will boost the valuation of Oric Pharmaceuticals. Anticipated expansion of Oric directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oric Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Oric Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Oric's balance sheet. Smart investors calculate Oric Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Oric Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Oric Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oric Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.